logo
Plus   Neg
Share
Email

Ascentage Collaborates With Acerta To Evaluate Combination Of Bcl-2 And BTK Inhibitors

Ascentage Pharma announced a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca (AZN,AZN.L).

As the terms of the collaboration, Ascentage will sponsor a clinical trial to study the combination of Ascentage Pharma's APG-2575, a selective Bcl-2 inhibitor, and Acerta's CALQUENCE.

CALQUENCE is a Bruton's Tyrosine Kinase (BTK) inhibitor, evaluating the efficacy and safety of the combination therapy in patients with relapsed/refractory (r/r) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

CLL/SLL is a hematologic malignancy caused by mature B-cell neoplasms and constitutes the most common form of adult leukemia in North America and Europe, accounting for about 30% of all new leukemia cases.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Home Depot, Inc. is set to open three new distribution centers in Georgia over the next 18 months, which is expected to create an additional 1,000 new jobs in Greater Atlanta, including full-time and part-time positions. The home improvement retailer has already created more than 5,000 new jobs in Georgia over the last five years. Shares of BMW AG were losing around 5 percent in German trading after the luxury car maker reported Wednesday a loss in its second quarter, compared to prior year's profit as demand was hit hard by coronavirus pandemic. Looking ahead, the company said it is cautiously optimistic for second half of the year, and reaffirmed fiscal 2020 outlook. Billionaire Richard Branson's Virgin Atlantic has filed for Chapter 15 bankruptcy protection in the United States after being hit hard by travel restrictions due to the coronavirus pandemic. The process is part of the British airline's restructuring plan as it is seeking a 1.2 billion pounds rescue deal in the U.K. The airline also filed a proceeding in the high court in London for its restructuri
Follow RTT